J9155 HCPCS code: Injection, degarelix, 1 mg
J9155 is the HCPCS Level II code for injection, degarelix, 1 mg. In 2024 Medicare paid an average of $3.26 per service for J9155 across 2,340,292 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 240 per day on outpatient hospital claims. Medicare volume fell 25% from 2022 to 2024 (3,111,231 to 2,340,292 services). In 2024, about 2,815 clinicians billed Medicare for J9155 for 6,517 beneficiaries; Florida, California, Maryland accounted for 25% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2010-01-01 |
| Last action effective | 2010-01-01 |
Who bills J9155 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,815 |
| Medicare beneficiaries | 6,517 |
| States with claims | 44 |
| Share of services in top 3 states (Florida, California, Maryland) | 25% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9155, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,111,231 | 8,468 | $3.97 | $3.12 |
| 2023 | 2,820,045 | 7,765 | $4.03 | $3.17 |
| 2024 | 2,340,292 | 6,517 | $4.15 | $3.26 |
States with the most J9155 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 275,062 | $3.28 |
| California | 166,508 | $3.24 |
| Maryland | 150,042 | $3.26 |
| New Jersey | 119,147 | $3.29 |
| Virginia | 111,047 | $3.25 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 240 | Prescribing Information |
| practitioner claims | 240 | Prescribing Information |
What changed for J9155
- 2010-01-01: J9155 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9155?
J9155 is the HCPCS Level II code for injection, degarelix, 1 mg. Short descriptor: "Degarelix injection".
How much does Medicare pay for J9155?
In 2024, the average Medicare payment was $3.26 per service (average allowed $4.15).
Does Medicare cover J9155?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9155 can be billed per day?
240 on outpatient hospital claims; 240 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9160 — Injection, denileukin diftitox, 300 micrograms
- J9161 — Injection, denileukin diftitox-cxdl, 1 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9155
- Watch J9155 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9155
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.